BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 21 filers reported holding BIOPHARMX CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $648,000 | +36.1% | 1,283,951 | +0.9% | 0.17% | -4.5% |
| Q4 2016 | $476,000 | +22.4% | 1,273,128 | +81.7% | 0.18% | +51.7% |
| Q3 2016 | $389,000 | -14.5% | 700,636 | 0.0% | 0.12% | -23.9% |
| Q2 2016 | $455,000 | -40.4% | 700,636 | 0.0% | 0.16% | -44.0% |
| Q1 2016 | $764,000 | +35.7% | 700,636 | +89.0% | 0.28% | +48.9% |
| Q4 2015 | $563,000 | +47.4% | 370,636 | 0.0% | 0.19% | +56.3% |
| Q3 2015 | $382,000 | -59.7% | 370,636 | 0.0% | 0.12% | -56.9% |
| Q2 2015 | $949,000 | – | 370,636 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 16,128,515 | $1,419,000 | 0.14% |
| FRG Family Wealth Advisors LLC | 30,000 | $3,000 | 0.00% |
| UBS Group AG | 38,029 | $3,000 | 0.00% |
| OPPENHEIMER & CO INC | 35,000 | $3,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 671,686 | $59,000 | 0.00% |
| BlackRock Inc. | 6,033 | $1,000 | 0.00% |
| LPL Financial LLC | 40,000 | $4,000 | 0.00% |
| Citadel Advisors | 413,489 | $36,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 12,264 | $1,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 137,625 | $12,000 | 0.00% |